全文获取类型
收费全文 | 2215篇 |
免费 | 216篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 153篇 |
妇产科学 | 36篇 |
基础医学 | 343篇 |
口腔科学 | 125篇 |
临床医学 | 273篇 |
内科学 | 386篇 |
皮肤病学 | 55篇 |
神经病学 | 151篇 |
特种医学 | 196篇 |
外科学 | 319篇 |
综合类 | 42篇 |
预防医学 | 123篇 |
眼科学 | 45篇 |
药学 | 86篇 |
中国医学 | 2篇 |
肿瘤学 | 117篇 |
出版年
2023年 | 16篇 |
2022年 | 15篇 |
2021年 | 16篇 |
2020年 | 19篇 |
2019年 | 10篇 |
2018年 | 52篇 |
2017年 | 61篇 |
2016年 | 50篇 |
2015年 | 74篇 |
2014年 | 94篇 |
2013年 | 119篇 |
2012年 | 82篇 |
2011年 | 57篇 |
2010年 | 94篇 |
2009年 | 116篇 |
2008年 | 60篇 |
2007年 | 84篇 |
2006年 | 96篇 |
2005年 | 64篇 |
2004年 | 76篇 |
2003年 | 49篇 |
2002年 | 50篇 |
2001年 | 42篇 |
2000年 | 33篇 |
1999年 | 54篇 |
1998年 | 113篇 |
1997年 | 96篇 |
1996年 | 105篇 |
1995年 | 68篇 |
1994年 | 78篇 |
1993年 | 43篇 |
1992年 | 31篇 |
1991年 | 33篇 |
1990年 | 24篇 |
1989年 | 39篇 |
1988年 | 39篇 |
1987年 | 42篇 |
1986年 | 29篇 |
1985年 | 35篇 |
1984年 | 14篇 |
1983年 | 12篇 |
1982年 | 28篇 |
1981年 | 22篇 |
1980年 | 18篇 |
1979年 | 16篇 |
1978年 | 11篇 |
1977年 | 12篇 |
1976年 | 16篇 |
1975年 | 11篇 |
1973年 | 10篇 |
排序方式: 共有2464条查询结果,搜索用时 15 毫秒
51.
52.
Phenobarbital and clofibrate, two non-genotoxic carcinogens, have been
investigated regarding the relationship between reactive oxygen species,
antioxidant enzyme expression and apoptosis in primary cultures of rat
hepatocytes. Low toxicity concentrations, 200 and 100 microg/ml for
phenobarbital and clofibrate respectively, were used to examine their
effect on spontaneous or transforming growth factor beta1
(TGFbeta1)-induced apoptosis and on the expression of antioxidant defence
enzymes (superoxide dismutases and catalase). The increased incidence of
apoptotic nuclei was visualized in TGFbeta1-treated cultures with the
fluorescent dye Hoechst 33258 and was quantified under all experimental
conditions by measurement of the hypodiploid peak in DNA histograms
obtained by flow cytometry. Both substances, when added separately to
hepatocyte cultures and incubated for 24 and 48 h, significantly diminished
spontaneous apoptosis and exhibited a slight suppression of
TGFbeta1-induced apoptosis. Endogenous peroxide production by hepatocytes
increased with TGFbeta1, phenobarbital or clofibrate and the increase was
greater with phenobarbital and in the presence of TGFbeta1 with both drugs.
Gene expression of catalase and Mn- and Cu,Zn superoxide dismutases (SOD)
was evaluated by northern blot analysis of hepatocytes incubated in the
presence of phenobarbital or clofibrate with or without TGFbeta1 and the
following differences were detected: phenobarbital induced a significant
decrease in both dismutases (to 56%, P < 0.05, and 55%, P < 0.05, for
Mn- and Cu,Zn-SOD respectively) and a 2-fold increase (P < 0.01) in
catalase; clofibrate induced a slight decrease in both SODs and a 4-fold
increase (P < 0.05) in catalase; TGFbeta1 significantly decreased to 37%
(P < 0.05) expression of catalase while not significantly affecting
expression of both SODs. We conclude that inhibition of spontaneous
apoptosis induced by either phenobarbital or clofibrate is accompanied by
increases in the endogenous levels of peroxides and by significant
induction of catalase gene expression. Furthermore, the lack of effect of
both compounds on TGFbeta1-induced apoptosis could be a consequence of the
inability of these two compounds to counteract the depressing effect of
TGFbeta1 on expression of catalase.
相似文献
53.
54.
55.
AM Halefoglu 《Journal of Medical Imaging and Radiation Oncology》2005,49(3):242-245
A pulmonary arteriovenous fistula is an abnormal connection between pulmonary arteries and veins. Patients with Rendu–Osler–Weber syndrome may present with this vascular malformation, which is a typical finding of the disease. Approximately 5–15% of Rendu–Osler–Weber syndrome patients have pulmonary arteriovenous malformations (AVM) and there is usually a family history of AVM in these patients. The malformations are usually located in the lower lobes. In this paper, I describe a 49‐year‐old male patient with dyspnoea, cough, haemoptysis and epistaxis. Physical examination showed nasal telangiectasias, cyanosis of the lips and nails, and a systolic bruit over the left lung. Chest X‐ray revealed a 5‐cm mass in the left lower lobe and after magnetic resonance examination, together with 3‐D magnetic resonance angiography, it was demonstrated to be a pulmonary arteriovenous fistula. The history of a niece with a similiar history of suspected pulmonary arteriovenous fistula led me to consider the possibility of Rendu–Osler–Weber syndrome presenting with a pulmonary arteriovenous fistula. 相似文献
56.
F. H. Rein Randerath Auersbach H. v. Kress Jores E. Wollheim L. Heilmeyer Begemann R. Siebeck Elze Amelung 《Journal of molecular medicine (Berlin, Germany)》1951,29(3-4):62-64
Ohne Zusammenfassung 相似文献
57.
L. Lichtwitz Rona Kress E. Simon Elze Stöhr Jr. Melchior Goldstein R. Gaupp E. Straus F. Goldmann Karl Freudenberg Koenigsfeld Melchior 《Journal of molecular medicine (Berlin, Germany)》1932,11(33):1396-1398
Ohne Zusammenfassung 相似文献
58.
W Nechwatal M Stauch H Sigel P Kress F Bitter H Geffers W E Adam 《Clinical cardiology》1981,4(5):248-253
Although the antianginal properties of molsidomine are well-established, little is known about its effects on global and regional left ventricular dysfunction secondary to myocardial ischemia. In the present study, left ventricular performance was assessed by radionuclide ventriculography at rest and during exercise in 15 patients with coronary artery disease (CAD) and angina pectoris before and after the administration of 2 mg molsidomine sublingually. Gated blood pool studies were performed for evaluation of left ventricular ejection fraction (LVEF) and regional wall motion by analyzing amplitudes and phases of the first Fourier coefficient of regional time–activity curves. In contrast to normal subjects, during the control study period LVEF in patients with CAD decreased from 50.9% at rest to 42.7% during exercise (p<0.01). After molsidomine the resting values of LVEF increased slightly from 50.9% to 55.7% (p<0.05). Exercise values of LVEF increased from 42.7% to 51.3% (p<0.01). This is usually associated with amelioration of anginal pain and ischemic ST depression in the precordial ECG (0.15 mV vs. 0.09 mV; p<0.01). Before molsidomine, regional wall motion deteriorated from rest to exercise in 11 of 15 patients. These wall motion abnormalities usually expressed themselves as newly developed regions of left ventricular dysfunction (8 patients) or as accentuation of pre-existing contraction disturbances (3 patients). After molsidomine, regional wall motion did not show consistent changes at rest. Comparison during exercise showed enhanced regional function in 10 of the 15 patients after administration of the drug. At rest a slight but significant increase in heart rate was measured following molsidomine, whereas exercise heart rate remained unchanged. Only minor changes in systolic blood pressure occurred after molsidomine (rest, 143 mmHg vs. 134 mmHg; p<0.05; exercise, 177 mmHg vs. 174 mmHg; p>0.10). In conclusion, assessment of left ventricular performance at rest and during exercise in patients with CAD revealed significant improvement of global and regional left ventricular function, indicating reduction of myocardial ischemia. These effects may result primarily from reduction of left ventricular wall tension. 相似文献
59.
Jacqueline AM Smith DL Patil OT Daniels Y-S Ding J-D Gallezot S Henry KHS Kim S Kshirsagar WJ Martin GP Obedencio E Stangeland PR Tsuruda W Williams RE Carson ST Patil 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2015,18(2)